Literature DB >> 17911539

Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging.

Ann D King1, Anil T Ahuja, David K W Yeung, Devin K Y Fong, Yolanda Y P Lee, Kenny I K Lei, Gary M K Tse.   

Abstract

PURPOSE: To prospectively determine the diagnostic accuracy of diffusion-weighted magnetic resonance (MR) imaging for discrimination of malignant neck nodes due to lymphoma, squamous cell carcinoma (SCC), and undifferentiated nasopharyngeal carcinoma (NPC), with histologic findings and imaging criteria as reference standards.
MATERIALS AND METHODS: Ethics committee approval and informed consent were obtained. Patients with malignant lymphadenopathy underwent 1.5-T diffusion-weighted MR imaging. A region of interest was drawn around the malignant node on apparent diffusion coefficient (ADC) maps; ADC values were compared (Kruskal-Wallis test). Receiver operating characteristic analysis was employed to investigate whether ADC values could aid in discrimination among malignancies.
RESULTS: Forty-three patients (34 men, nine women; mean age, 54 years) with 43 nodes underwent imaging. Mean ADC values for lymphoma (n = 8), NPC (n = 17), and SCC (n = 18) were (0.664 +/- 0.071 [standard deviation]) x 10(-3) mm(2)/sec, (0.802 +/- 0.128) x 10(-3) mm(2)/sec, and (1.057 +/- 0.169) x 10(-3) mm(2)/sec, respectively, with significant differences between SCC and lymphoma or NPC (P < .001) and between NPC and lymphoma (P = .04). To optimize sensitivity and specificity with equal weighting, ADC threshold values for distinguishing between SCC and NPC, between SCC and lymphoma, and between NPC and lymphoma were 0.894 x 10(-3) mm(2)/sec, 0.824 x 10(-3) mm(2)/sec, and 0.694 x 10(-3) mm(2)/sec, respectively. To produce a 100% specificity while sensitivity is maximized, the following ADC threshold values were obtained for prediction of differentiation between malignancies: (a) SCC versus lymphoma, greater than 0.824 x 10(-3) mm(2)/sec (sensitivity, 94%), and lymphoma versus SCC, less than 0.767 x 10(-3) mm(2)/sec (sensitivity 88%); (b) NPC versus SCC, less than 0.764 x 10(-3) mm(2)/sec (sensitivity, 47%), and SCC versus NPC, greater than 1.093 x 10(-3) mm(2)/sec (sensitivity, 39%); (c) NPC versus lymphoma, greater than 0.788 x 10(-3) mm(2)/sec (sensitivity, 53%), and lymphoma versus NPC, no suitable threshold value.
CONCLUSION: Diffusion-weighted MR imaging shows significant differences among malignant nodes of SCC, lymphoma, and NPC. ADC threshold values can help distinguish SCC from lymphoma. SUPPLEMENTAL MATERIAL: http://radiology.rsnajnls.org/cgi/content/full/2451061804/DC1.

Entities:  

Mesh:

Year:  2007        PMID: 17911539     DOI: 10.1148/radiol.2451061804

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  56 in total

1.  Contrast-enhanced CT and MRI for detecting neck metastasis of oral cancer: comparison between analyses performed by oral and medical radiologists.

Authors:  P T de Souza Figueiredo; A F Leite; F R Barra; R F Dos Anjos; A C Freitas; L A Nascimento; N S Melo; E N S Guerra
Journal:  Dentomaxillofac Radiol       Date:  2012-01-12       Impact factor: 2.419

2.  Can diffusion-weighted imaging distinguish between normal and squamous cell carcinoma of the palatine tonsil?

Authors:  K S S Bhatia; A D King; D K W Yeung; F Mo; A C Vlantis; K-H Yu; J K T Wong; A T Ahuja
Journal:  Br J Radiol       Date:  2010-07-20       Impact factor: 3.039

3.  Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma.

Authors:  Chieh Lin; Alain Luciani; Emmanuel Itti; Taoufik El-Gnaoui; Alexandre Vignaud; Pauline Beaussart; Shih-jui Lin; Karim Belhadj; Pierre Brugières; Eva Evangelista; Corinne Haioun; Michel Meignan; Alain Rahmouni
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

4.  Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.

Authors:  Ann D King; Frankie K F Mo; Kwok-Hung Yu; David K W Yeung; Hua Zhou; Kunwar S Bhatia; Gary M K Tse; Alexander C Vlantis; Jeffrey K T Wong; Anil T Ahuja
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

5.  Diffusion MR imaging features of skull base osteomyelitis compared with skull base malignancy.

Authors:  B Ozgen; K K Oguz; A Cila
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-14       Impact factor: 3.825

6.  Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.

Authors:  Vincent Vandecaveye; Piet Dirix; Frederik De Keyzer; Katya Op de Beeck; Vincent Vander Poorten; I Roebben; Sandra Nuyts; Robert Hermans
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

7.  Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.

Authors:  R B J de Bondt; M C Hoeberigs; P J Nelemans; W M L L G Deserno; C Peutz-Kootstra; B Kremer; R G H Beets-Tan
Journal:  Neuroradiology       Date:  2009-01-10       Impact factor: 2.804

8.  Diffusion-weighted MR imaging of thyroid nodules.

Authors:  Zulkif Bozgeyik; Sonay Coskun; A Ferda Dagli; Yusuf Ozkan; Fatih Sahpaz; Erkin Ogur
Journal:  Neuroradiology       Date:  2009-01-23       Impact factor: 2.804

9.  Nasopharyngeal carcinoma: correlation of apparent diffusion coefficient value with prognostic parameters.

Authors:  Ahmed Abdel Khalek Abdel Razek; Elsharawey Kamal
Journal:  Radiol Med       Date:  2012-10-22       Impact factor: 3.469

10.  Anatomical and functional volume concordance between FDG PET, and T2 and diffusion-weighted MRI for cervical cancer: a hybrid PET/MR study.

Authors:  Hongzan Sun; Jun Xin; Shaomin Zhang; Qiyong Guo; Yueyue Lu; Wei Zhai; Long Zhao; Weiai Peng; Baijun Wang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-01-25       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.